The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Molecular Blood Market Research Report 2025
Synopsis
Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. However, some segments have thrived and others are seeing mature growth levels.
The global Molecular Blood market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Molecular Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Blood.
Report Scope
The Molecular Blood market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Blood market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Blood companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
QIAGEN
Roche Diagnostics
Hologic
Grifols
Siemens Healthcare
Becton, Dickinson
Danaher
Biomerieux
Cepheid
Segment by Type
PCR
PCR-RFLP
AS-PCR or PCR-SSP
Multiplex PCR
Real Time PCR
Sanger DNA Sequencing
Pyrosequencing
Segment by Application
Blood Centers
Hospitals
Commercial/Private Laboratories
Military Blood Banks
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Blood companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Molecular testing provides fast and accurate results and the prescence of molecular tests has disrupted several testing markets over the past decade and a half. However, some segments have thrived and others are seeing mature growth levels.
The global Molecular Blood market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Molecular Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Blood.
Report Scope
The Molecular Blood market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Molecular Blood market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Molecular Blood companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
QIAGEN
Roche Diagnostics
Hologic
Grifols
Siemens Healthcare
Becton, Dickinson
Danaher
Biomerieux
Cepheid
Segment by Type
PCR
PCR-RFLP
AS-PCR or PCR-SSP
Multiplex PCR
Real Time PCR
Sanger DNA Sequencing
Pyrosequencing
Segment by Application
Blood Centers
Hospitals
Commercial/Private Laboratories
Military Blood Banks
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Blood companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Blood Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 PCR-RFLP
1.2.4 AS-PCR or PCR-SSP
1.2.5 Multiplex PCR
1.2.6 Real Time PCR
1.2.7 Sanger DNA Sequencing
1.2.8 Pyrosequencing
1.3 Market by Application
1.3.1 Global Molecular Blood Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood Centers
1.3.3 Hospitals
1.3.4 Commercial/Private Laboratories
1.3.5 Military Blood Banks
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Blood Market Perspective (2019-2030)
2.2 Molecular Blood Growth Trends by Region
2.2.1 Global Molecular Blood Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Molecular Blood Historic Market Size by Region (2019-2024)
2.2.3 Molecular Blood Forecasted Market Size by Region (2025-2030)
2.3 Molecular Blood Market Dynamics
2.3.1 Molecular Blood Industry Trends
2.3.2 Molecular Blood Market Drivers
2.3.3 Molecular Blood Market Challenges
2.3.4 Molecular Blood Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Blood Players by Revenue
3.1.1 Global Top Molecular Blood Players by Revenue (2019-2024)
3.1.2 Global Molecular Blood Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Blood Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Blood Revenue
3.4 Global Molecular Blood Market Concentration Ratio
3.4.1 Global Molecular Blood Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Blood Revenue in 2023
3.5 Molecular Blood Key Players Head office and Area Served
3.6 Key Players Molecular Blood Product Solution and Service
3.7 Date of Enter into Molecular Blood Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Blood Breakdown Data by Type
4.1 Global Molecular Blood Historic Market Size by Type (2019-2024)
4.2 Global Molecular Blood Forecasted Market Size by Type (2025-2030)
5 Molecular Blood Breakdown Data by Application
5.1 Global Molecular Blood Historic Market Size by Application (2019-2024)
5.2 Global Molecular Blood Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Molecular Blood Market Size (2019-2030)
6.2 North America Molecular Blood Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Molecular Blood Market Size by Country (2019-2024)
6.4 North America Molecular Blood Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Blood Market Size (2019-2030)
7.2 Europe Molecular Blood Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Molecular Blood Market Size by Country (2019-2024)
7.4 Europe Molecular Blood Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Blood Market Size (2019-2030)
8.2 Asia-Pacific Molecular Blood Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Molecular Blood Market Size by Region (2019-2024)
8.4 Asia-Pacific Molecular Blood Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Blood Market Size (2019-2030)
9.2 Latin America Molecular Blood Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Molecular Blood Market Size by Country (2019-2024)
9.4 Latin America Molecular Blood Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Blood Market Size (2019-2030)
10.2 Middle East & Africa Molecular Blood Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Molecular Blood Market Size by Country (2019-2024)
10.4 Middle East & Africa Molecular Blood Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Blood Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Blood Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Molecular Blood Introduction
11.2.4 QIAGEN Revenue in Molecular Blood Business (2019-2024)
11.2.5 QIAGEN Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Molecular Blood Introduction
11.3.4 Roche Diagnostics Revenue in Molecular Blood Business (2019-2024)
11.3.5 Roche Diagnostics Recent Development
11.4 Hologic
11.4.1 Hologic Company Detail
11.4.2 Hologic Business Overview
11.4.3 Hologic Molecular Blood Introduction
11.4.4 Hologic Revenue in Molecular Blood Business (2019-2024)
11.4.5 Hologic Recent Development
11.5 Grifols
11.5.1 Grifols Company Detail
11.5.2 Grifols Business Overview
11.5.3 Grifols Molecular Blood Introduction
11.5.4 Grifols Revenue in Molecular Blood Business (2019-2024)
11.5.5 Grifols Recent Development
11.6 Siemens Healthcare
11.6.1 Siemens Healthcare Company Detail
11.6.2 Siemens Healthcare Business Overview
11.6.3 Siemens Healthcare Molecular Blood Introduction
11.6.4 Siemens Healthcare Revenue in Molecular Blood Business (2019-2024)
11.6.5 Siemens Healthcare Recent Development
11.7 Becton, Dickinson
11.7.1 Becton, Dickinson Company Detail
11.7.2 Becton, Dickinson Business Overview
11.7.3 Becton, Dickinson Molecular Blood Introduction
11.7.4 Becton, Dickinson Revenue in Molecular Blood Business (2019-2024)
11.7.5 Becton, Dickinson Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Molecular Blood Introduction
11.8.4 Danaher Revenue in Molecular Blood Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Biomerieux
11.9.1 Biomerieux Company Detail
11.9.2 Biomerieux Business Overview
11.9.3 Biomerieux Molecular Blood Introduction
11.9.4 Biomerieux Revenue in Molecular Blood Business (2019-2024)
11.9.5 Biomerieux Recent Development
11.10 Cepheid
11.10.1 Cepheid Company Detail
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Molecular Blood Introduction
11.10.4 Cepheid Revenue in Molecular Blood Business (2019-2024)
11.10.5 Cepheid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
